What is the treatment for Candida urinary tract infections (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Candida Urinary Tract Infections

For symptomatic Candida UTI, fluconazole 200 mg (3 mg/kg) orally daily for 2 weeks is the first-line treatment, while asymptomatic candiduria typically requires no treatment unless the patient is neutropenic, a very low-birth-weight infant, or undergoing urologic procedures. 1, 2

Initial Assessment: Distinguish Infection from Colonization

  • Most candiduria represents colonization or contamination, not true infection 3, 4
  • Remove or replace urinary catheters immediately if feasible—this alone resolves candiduria in approximately 50% of cases 5, 6
  • Eliminate other predisposing factors (broad-spectrum antibiotics, urinary obstruction) as this often results in spontaneous resolution 1, 7
  • Do NOT treat asymptomatic candiduria in most patients 1, 2

High-Risk Patients Requiring Treatment Despite Asymptomatic Candiduria:

  • Neutropenic patients 1, 2
  • Very low-birth-weight infants 1, 8
  • Patients undergoing urologic procedures (treat prophylactically with fluconazole 200-400 mg daily or amphotericin B deoxycholate 0.3-0.6 mg/kg daily for several days before and after the procedure) 1, 2

Treatment Algorithm for Symptomatic Candida UTI

Candida Cystitis (Lower UTI):

  • Fluconazole 200 mg (3 mg/kg) orally daily for 2 weeks is the drug of choice for fluconazole-susceptible species 1, 5, 9
  • Fluconazole achieves high urinary concentrations in its active form and has demonstrated 82% efficacy 8, 3

Candida Pyelonephritis (Upper UTI):

  • Fluconazole 200-400 mg (3-6 mg/kg) orally daily for 2 weeks for fluconazole-susceptible organisms 1, 5
  • Use the higher dose (400 mg) for more severe upper tract infections 8

Alternative Regimens for Fluconazole-Resistant Organisms (especially C. glabrata and C. krusei):

  • Amphotericin B deoxycholate 0.3-0.6 mg/kg IV daily for 1-7 days 1, 2
  • Flucytosine 25 mg/kg orally 4 times daily for 7-10 days (use with caution due to toxicity and resistance development when used alone) 1
  • For pyelonephritis with resistant organisms: Amphotericin B deoxycholate 0.5-0.7 mg/kg daily with or without flucytosine 25 mg/kg 4 times daily for 2 weeks 1

Critical Pharmacologic Considerations

Why fluconazole is preferred:

  • Achieves high urinary concentrations in active form 1, 7
  • Available in both oral and IV formulations 3, 6
  • Excellent safety profile 3

Agents to AVOID for Candida UTI:

  • Do NOT use echinocandins (caspofungin, micafungin, anidulafungin) for lower UTI—they achieve minimal urinary concentrations and are generally ineffective 5, 3
  • Do NOT use other azoles besides fluconazole (itraconazole, voriconazole, posaconazole)—they have minimal excretion of active drug into urine 1, 6
  • Do NOT use lipid formulations of amphotericin B—they do not achieve adequate urine or renal tissue concentrations and have documented treatment failures 1, 5

Special Clinical Scenarios

Fungus Balls:

  • Require aggressive surgical debridement in addition to systemic antifungal therapy 1, 8
  • If percutaneous access available, consider irrigation with amphotericin B 50 mg/L sterile water as adjunct to systemic therapy 1

Suspected Disseminated Candidiasis with Candiduria:

  • Treat as candidemia with systemic antifungal therapy, not as isolated UTI 1

Amphotericin B Bladder Irrigation:

  • Generally NOT recommended due to high relapse rates (though resolves candiduria in 80-90% initially) 1, 2
  • May be considered only for refractory cystitis due to fluconazole-resistant C. glabrata or C. krusei 1

Treatment Duration and Monitoring

  • Continue treatment until symptoms resolve AND urine cultures no longer yield Candida species 1, 5
  • Standard duration is 2 weeks for uncomplicated cystitis and pyelonephritis 1, 8
  • Obtain follow-up urine cultures to confirm clearance 5
  • If treatment fails despite appropriate therapy, obtain imaging to rule out anatomical abnormalities, fungus balls, hydronephrosis, or abscesses 5, 8

Common Pitfalls to Avoid

  • Colony count cannot reliably differentiate colonization from infection, especially with catheters in place 2
  • Do not treat asymptomatic candiduria reflexively—elimination of predisposing factors alone is often sufficient 1, 7
  • Do not use fluconazole if the patient was already on fluconazole prophylaxis, as resistance is likely 1
  • Address urinary tract obstruction—it is critical to treatment success and must be corrected 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Urine Candida Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections--treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Research

Nosocomial candiduria: a review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001

Guideline

Treatment of Candida Lusitaniae Urinary Tract Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Research

Candida urinary tract infections in adults.

World journal of urology, 2020

Guideline

Treatment of Candida tropicalis UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.